Merck & Co. And Gates Foundation Drug Hunters Hopeful Of A TB Breakthrough
Not-For-Profit To Develop Merck’s Compounds
The Bill & Melinda Gates Foundation has brought together big pharma companies and academic institutes in a non-profit venture to find new drugs to improve tuberculosis treatment. One participant, Merck & Co, talks to Scrip about two promising novel molecules that it discovered for the Foundation’s Medical Research Institute to develop.
